Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cancer Pain × cannabichromene × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Morphine 15 Oxycodone 12 Methadone 7 Fentanyl 6 Lidocaine 5 Acetaminophen 5 nabiximols 4 Ethanol 4 resiniferatoxin 3 Transcutaneous Electric Nerve Stimulation 3 Hydromorphone 3 Buprenorphine 3 Acupuncture Therapy 3 Tapentadol 2 Surveys and Questionnaires 2 Standard of Care 2 Sodium Bicarbonate 2 Radiofrequency Ablation 2 Pharmaceutical Services 2 Ketamine 2 Control Groups 2 Analgesics, Opioid 2 tanezumab 1 rofecoxib 1 oxycodone naloxone combination 1 naloxegol 1 incobotulinumtoxinA 1 fulranumab 1 cannabichromene 1 Water 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06533657 2026-03-12

UTOPIA-1

ZYUS Life Sciences Inc.

Phase 2 Active not recruiting

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡